Hemoglobin-Based Oxygen Carriers: Selected Advances and Challenges in the Design of Safe Oxygen Therapeutics (A Focused Review)
International Journal of Molecular Sciences · 08.10.2025 · 26 (19) · 9775
DOI: 10.3390/ijms26199775 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.10.2025. Verfasst von Waldemar Grzegorzewski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Nature Protection, and Sustainable Development, University of Rzeszow, 35-310 Rzeszow, Poland. Hauptthemen laut MEDLINE: Blood Substitutes, Hemoglobins, Oxygen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Blood transfusion is a routine yet resource-intensive medical procedure. Increasing global demand, limited donor availability, and logistical and ethical constraints have driven the search for adequate blood substitutes. Hemoglobin-based oxygen carriers (HBOCs) represent a promising class of therapeutics designed to mimic the oxygen transport function of red blood cells while overcoming the challenges of storage, compatibility, and infection risk. Despite decades of research, no HBOC has yet met all criteria for widespread clinical use. This review summarizes recent advances in the design and development of hemoglobin derivatives, with a focus on their biochemical properties, safety profiles, and oxygen delivery capabilities. We also discuss current limitations and translational barriers. The successful implementation of HBOCs could significantly improve transfusion strategies, especially in emergency medicine, military applications, and resource-limited settings. Continued innovation is essential to bring safe and effective oxygen therapeutics into routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biology, Nature Protection, and Sustainable Development, University of Rzeszow, 35-310 Rzeszow, Poland.
- Faculty of Medicine, Department of Pharmaceutical Technology and Medical Physics, University of Rzeszow, 35-959 Rzeszow, Poland.
- Independent Researcher, 02-777 Warsaw, Poland.
- Department of Basic and Clinical Sciences, TOURO College of Osteopathic Medicine, Middletown, NY 10940, USA.
- OXYVITA Inc., Middletown, NY 10940, USA.
- Department of Pharmacology and Toxicology, Faculty of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland.
ORCID-Profile: Waldemar Grzegorzewski, Anna Czerniecka-Kubicka, Katarzyna Gołda, Hanna Wollocko, Michał S Majewski, Joanna Wojtkiewicz
Zitieren
APA
Grzegorzewski, W., Czerniecka-Kubicka, A., Gołda, K., Niedźwiedzka, A., Wollocko, H., Majewski, M. S., & Wojtkiewicz, J. (2025). Hemoglobin-Based Oxygen Carriers: Selected Advances and Challenges in the Design of Safe Oxygen Therapeutics (A Focused Review). International Journal of Molecular Sciences, 26(19), 9775. https://doi.org/10.3390/ijms26199775
Vancouver
Grzegorzewski W, Czerniecka-Kubicka A, Gołda K, Niedźwiedzka A, Wollocko H, Majewski MS, et al. Hemoglobin-Based Oxygen Carriers: Selected Advances and Challenges in the Design of Safe Oxygen Therapeutics (A Focused Review). International Journal of Molecular Sciences. 2025;26(19):9775. doi:10.3390/ijms26199775
BibTeX
@article{Grzegorzewski2025,
author = {Grzegorzewski, Waldemar and Czerniecka-Kubicka, Anna and Gołda, Katarzyna and Niedźwiedzka, Alicja and Wollocko, Hanna and Majewski, Michał S and Wojtkiewicz, Joanna},
title = {Hemoglobin-Based Oxygen Carriers: Selected Advances and Challenges in the Design of Safe Oxygen Therapeutics (A Focused Review)},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9775},
doi = {10.3390/ijms26199775}
}
EUVIMED